View by Specialty

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

Infection News

SPONSORED CONTENT
Save
SPONSORED CONTENT
October 10, 2022
24 min listen
Save

Long COVID: Some facts, unanswered questions and implications for rheumatology – Part 2

Long COVID: Some facts, unanswered questions and implications for rheumatology – Part 2

In part two, Leonard Calabrese, DO, discusses the symptoms of long COVID and the role that rheumatologists play in diagnosing and treating patients with long COVID.

SPONSORED CONTENT
October 06, 2022
2 min read
Save

COVID-19 vaccines 87% effective at preventing hospitalization in immunosuppressed patients

COVID-19 vaccines 87% effective at preventing hospitalization in immunosuppressed patients

Three doses of either the BNT162b2 or mRNA-1273 vaccine are 87% effective at preventing hospitalization due to COVID-19 among patients taking immunosuppressive drugs, according to data published in The Lancet Rheumatology.

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

SPONSORED CONTENT
October 05, 2022
2 min read
Save

Evusheld, aggressive therapy may reduce COVID-19 severity in patients on B-cell depletion

Evusheld, aggressive therapy may reduce COVID-19 severity in patients on B-cell depletion

Pre-exposure prophylaxis with Evusheld, combined with aggressive outpatient treatment, may reduce COVID-19 severity in patients with immune-mediated inflammatory disease on B-cell depletion, according to a letter published in RMB Open.

SPONSORED CONTENT
October 04, 2022
1 min read
Save

FDA: Evusheld may lack efficacy against upcoming COVID-19 subvariants

FDA: Evusheld may lack efficacy against upcoming COVID-19 subvariants

Evusheld demonstrates reduced protection against the omicron subvariant BA.4.6, resulting in an increased risk for infection in those exposed to that COVID-19 strain, according to an updated FDA fact sheet.

SPONSORED CONTENT
October 03, 2022
2 min read
Save

Patients with IMIDs demonstrate lower, less durable COVID-19 vaccine response

Patients with IMIDs demonstrate lower, less durable COVID-19 vaccine response

Patients with immune-mediated inflammatory diseases demonstrate a lower, less durable COVID-19 vaccine response and are at risk for losing humoral immune protection, according to data published in The Lancet Rheumatology.

SPONSORED CONTENT
September 30, 2022
21 min listen
Save

Long COVID: Some facts, unanswered questions and implications for rheumatology – Part 1

Long COVID: Some facts, unanswered questions and implications for rheumatology – Part 1

In this episode, Leonard H. Calabrese, DO, reviews the history and controversies of post-infection sequelae, as well as the facts and epidemiology of long COVID.

SPONSORED CONTENT
September 29, 2022
2 min read
Save

Approximately 1 in 8 patients with COVID-19 experience long COVID

Approximately 1 in 8 patients with COVID-19 experience long COVID

Post-COVID, or long COVID, can develop in approximately one in eight people with COVID-19, according to data published in The Lancet.

SPONSORED CONTENT
September 27, 2022
2 min read
Save

Infections more common in patients with RA receiving tofacitinib vs TNF inhibitors

Infections more common in patients with RA receiving tofacitinib vs TNF inhibitors

Infections are more common in patients with rheumatoid arthritis who receive tofacitinib compared with those who receive TNF inhibitors, according to data published in the Annals of the Rheumatic Diseases.

SPONSORED CONTENT
September 26, 2022
2 min read
Save

Non-bivalent COVID-19 boosters fail to protect against omicron in patients with ARDs

Non-bivalent COVID-19 boosters fail to protect against omicron in patients with ARDs

After a third COVID-19 vaccine dose, patients with autoimmune rheumatic diseases often fail to mount an effective response useful in preventing omicron breakthrough infection, according to data published in Annals of the Rheumatic Diseases.

SPONSORED CONTENT
September 22, 2022
2 min read
Save

Air pollution, population mobility contribute to COVID-19 mortality risk

Air pollution, population mobility contribute to COVID-19 mortality risk

Regional socioeconomic conditions, air pollution, population mobility and the availability of health resources are all factors that impact the risk for death attributed to COVID-19 in patients with rheumatic diseases, according to data.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails